Latina Pharma S.p.A. (manufacturing, primary packaging, secondary packaging, quality control, batch release, stability testing)

The drug is used to achieve and maintain remission in acute non-lymphoblastic leukemias in adults and children, as well as for the treatment of other types of leukemias (e.g., acute lymphocytic or chronic myeloblastic) and non-Hodgkin lymphomas in children. It is also used for the prevention or treatment of leukemic meningitis.

Dosage form: lyophilisate for solution for injection

ATC: L01BC01